Can a patient-tailored treatment approach for Graves' disease reduce mortality?

Lancet Diabetes Endocrinol. 2019 Apr;7(4):245-246. doi: 10.1016/S2213-8587(19)30057-9. Epub 2019 Feb 28.

Authors

Luigi Bartalena¹, Eliana Piantanida², Maria Laura Tanda²

Affiliations

¹ Department of Medicine and Surgery, University of Insubria, Varese, 21100 Italy. Electronic address: luigi.bartalena@uninsubria.it.
² Department of Medicine and Surgery, University of Insubria, Varese, 21100 Italy.

PMID: 30827828
DOI: 10.1016/S2213-8587(19)30057-9

No abstract available

Publication types

Comment

MeSH terms

Antithyroid Agents
Cardiovascular Diseases*
Cohort Studies
Graves Disease*
Humans

Substances

Antithyroid Agents